Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy
Crossref DOI link: https://doi.org/10.1136/jitc-2022-006001
Published Online: 2023-02-23
Published Print: 2023-02
Update policy: https://doi.org/10.1136/crossmarkpolicy
Plewa, Natalia https://orcid.org/0000-0002-5888-297X
Poncette, Lucia
Blankenstein, Thomas
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB-TR36 (Sonderforschungsbereich TR36))
European Union (ERC Advanced Grant 882963)
Berlin School of Integrative Oncology (N/A)
Berlin Institute of Health (N/A)
License valid from 2023-02-23